BioSpace News Archive

Acadia Pharmaceuticals Inc. Conference call and webcast to be held today at 8:00 a.m. Eastern Time

IVERIC bio, Inc. announced that David R. Guyer, MD, co-founder and Executive Chairman, is stepping down from the Iveric Bio Board after 14 years, effective following Iveric Bio’s 2021 Annual Stockholder Meeting scheduled to be held on May 19, 2021.

Recro Pharma, Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced significant recent progress in strengthening the company’s business development team to support its strategic objective of expanding and diversifying its customer base.

Softgel comprises a gelatin-based shell encompassing a semi-solid or liquid medication or concentrate filled inside it. Softgel capsules offer several advantages to customers, for example, easy usability, improved adequacy, and bioavailability.

Meniscus plays an important role in human knee and has various functions such as shock absorption, load transmission across the knee joint, and joint nutrition.

Pharmaceutical sterility testing is an investigation of the microorganisms. This sterility test conducted with help of fungistasis and bacteriostasis testing.

Ultrasound is a medical imaging technology that involves use of high-frequency sound waves to visualize the internal body organs.

Fainting caused by a fall in blood pressure is known as syncope in medical parlance. Its onset is swift and sudden and its duration is short with spontaneous recovery.

The growth of the global cervical dysplasia market can be attributed to advancements in female healthcare.

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, announced the appointment of an additional member to its Board of Directors.